PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Turkish Cargo continued its steady growth in 2019

According to the international air cargo information provider WACD's December data (cumulative), the global air cargo brand Turkish Cargo, which serves 127 countries...
Continue Reading →
News

DATWYLER LAUNCHES NEOFLEX™ PLUNGERS OFFERING SUPERIOR FUNCTIONALITY AND COMPATIBILITY

Unveiled at Pharmapack, the no-added silicone sealing solution mitigates contamination threats. To help pharmaceutical and biotech developers better protect the in...
Continue Reading →
News

Reich Insurance launches innovative online Life Sciences insurance quote portal

Reich Group, a top 50 UK independent insurance broker, based in Manchester, today announces the launch of their new and unique online Life Sciences insurance quote p...
Continue Reading →
News

Almac Clinical Services’ Just in Time Manufacturing Operations Pass EU Regulatory Inspection

Craigavon, N.I., 18 February 2020 - Almac Clinical Services, a member of the global contract pharmaceutical development and manufacturing organisation, the Almac Gro...
Continue Reading →
News

Under-the-gun Acorda slashes Inbrija sales forecast amid lackluster launch

Acorda Therapeutics suffered a major blow in late 2018 when it lost four patents on multiple sclerosis med Ampyra. The drug cratered in the face of generic...
Continue Reading →
News

GBT takes a page from HIV playbook as it embarks on Oxbryta launch

The sickle cell disease market and patient support around the disease are both in the nascent stages. But Global Blood Therapeutics, a pioneer in the field with rece...
Continue Reading →
News

Has AstraZeneca lost its glow? Drugmaker misses on top cancer meds, braces for coronavirus

Oncology and China have been the main driving forces of AstraZeneca’s growth for some time now. But in the last three months of 2019, three of its key canc...
Continue Reading →
News

FDA anticipates disruptions, shortages as China outbreak plays out

The FDA is bracing for drug and medical supply shortages in the U.S. as the COVID-19 outbreak from China continues to spread globally. The agency has contacted hundr...
Continue Reading →
News

KTE-X19 bags FDA Priority Review in mantle cell lymphoma

Kite has announced that the US Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA), and granted Priority Review designation for K...
Continue Reading →
News

UKRI launches ‘Nucleic Acid Therapy Accelerator’

The UK Research and Innovation (UKRI) organisation has announced the launch of a new “Nucleic Acid Therapy Accelerator” (NATA). The body has revealed that the NATA...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026